This groundbreaking technology, developed over a decade by Professor Tony Hu’s renowned research group at Tulane University, has demonstrated ultrasensitive and highly specific capabilities. Their findings, published in numerous prestigious journals, highlight the transformative potential of CRISPR diagnostics. The landmark publications are listed below:
Tuberculosis, a leading global cause of death, is often underdiagnosed in adults and children with HIV using sputum tests. Non-sputum assays are crucial for better diagnosis and treatment monitoring. This study explores ultrasensitive detection of M. tuberculosis cell-free DNA (Mtb-cfDNA) in blood for TB diagnosis and treatment response.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.